Results 181 to 190 of about 24,911 (203)

Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy

Cancer, 2010
Elias J Jabbour, Guillermo Garcia-Manero, Jorge Cortes   +2 more
exaly  

Decitabine—Bedside to bench

Critical Reviews in Oncology/Hematology, 2007
Jean-Pierre J Issa
exaly  

Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment

Cellular and Molecular Immunology, 2018
Xuetao Cao
exaly  

Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors

Cancer Letters, 2014
Weidong Han
exaly  

Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine

International Journal of Cancer, 2008
Frank Lyko
exaly  

Concise Drug Review: Azacitidine and Decitabine

Oncologist, 2013
Jan H M Schellens, Jos Beijnen
exaly  

Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcome

Cancer, 2007
Hagop M Kantarjian, Guillermo Garcia-Manero, Elias J Jabbour   +2 more
exaly  

Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML

Blood, 2011
Joseph Michael Scandura, Fabienne Brenet
exaly  

Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia

Cancer, 2007
Gautam Borthakur, Farhad Ravandi, Jorge Cortes   +2 more
exaly  

Decitabine

Reactions Weekly, 2012
openaire   +1 more source